Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review-Reference-Cited by-同舟云学术

Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review

Published:2016-08-24 Issue:8 Volume:11 Page:e0160540
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fadlallah Racha,Nas Hala,Naamani Dana,El-Jardali Fadi,Hammoura Ihsan,Al-Khaled Lina,Brax Hneine,Kahale Lara,Akl Elie A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference78 articles.

1. Pharmaceutical promotional Spending: global trends;C Wooden;Secondary Pharmaceutical promotional Spending: global trends,2013

2. United States private-sector physicians and pharmaceutical contract research: a qualitative study;JA Fisher;PLoS medicine,2012

3. ACCME. ccreditation Council for Continuing Medical Education annual report data. 2006.

4. Doctors and drug companies—scrutinizing influential relationships;EG Campbell;The New England journal of medicine,2007

5. 2002. Kaiser Family Foundation. National Survey of Physicians. Part II: Doctors and Prescription Drugs. Washington, DC.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare consumers’ perceptions of incentive-linked prescribing: A scoping review;PLOS Global Public Health;2024-06-27

2. Healthcare Consumers’ Perceptions of Incentive-Linked Prescribing: A Scoping Review of Research;2024-02-28

3. Beliefs and practices of physicians in Lebanon regarding promotional gifts and interactions with pharmaceutical companies;Eastern Mediterranean Health Journal;2024-02-25

4. Pharmaceutical industry‐sponsored meals are associated with increased prescriptions and Medicare spending for dupilumab among dermatologists in the United States;Journal of Evaluation in Clinical Practice;2023-12-27

5. Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019;Cureus;2023-08-17